US7527644B2 - Stent with geometry determinated functionality and method of making the same - Google Patents

Stent with geometry determinated functionality and method of making the same Download PDF

Info

Publication number
US7527644B2
US7527644B2 US10/288,615 US28861502A US7527644B2 US 7527644 B2 US7527644 B2 US 7527644B2 US 28861502 A US28861502 A US 28861502A US 7527644 B2 US7527644 B2 US 7527644B2
Authority
US
United States
Prior art keywords
medical appliance
scaffolding
appliance
circumferential bands
stent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime, expires
Application number
US10/288,615
Other versions
US20040088040A1 (en
Inventor
Eric K. Mangiardi
Jason M Reynolds
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merit Medical Systems Inc
Original Assignee
Alveolus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alveolus Inc filed Critical Alveolus Inc
Priority to US10/288,615 priority Critical patent/US7527644B2/en
Priority to US10/669,450 priority patent/US7637942B2/en
Priority to US10/674,972 priority patent/US7875068B2/en
Assigned to ALVEOLUS INC reassignment ALVEOLUS INC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MANGIARDI, ERIC K., REYNOLDS, JASON M.
Priority to CA002505121A priority patent/CA2505121A1/en
Priority to AU2003284180A priority patent/AU2003284180B2/en
Priority to PCT/US2003/034075 priority patent/WO2004043221A2/en
Priority to DE60328507T priority patent/DE60328507D1/en
Priority to EP03776570A priority patent/EP1558178B1/en
Priority to JP2004551583A priority patent/JP4431046B2/en
Priority to US10/718,217 priority patent/US7959671B2/en
Publication of US20040088040A1 publication Critical patent/US20040088040A1/en
Priority to PCT/US2004/039162 priority patent/WO2005110282A1/en
Publication of US7527644B2 publication Critical patent/US7527644B2/en
Application granted granted Critical
Assigned to MERIT MEDICAL SYSTEMS, INC. reassignment MERIT MEDICAL SYSTEMS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ALVEOLUS, INC.
Priority to US12/616,455 priority patent/US8206436B2/en
Assigned to WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT reassignment WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT PATENT SECURITY AGREEMENT Assignors: MERIT MEDICAL SYSTEMS, INC.
Adjusted expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/856Single tubular stent with a side portal passage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91575Adjacent bands being connected to each other connected peak to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0018Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0051Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in tissue ingrowth capacity, e.g. made from both ingrowth-promoting and ingrowth-preventing parts

Definitions

  • the present invention relates generally to medical devices directed to the prevention of luminal occlusion, and more particularly to stents and methods for making and utilizing these stents in the treatment of both benign and malignant conditions wherein the functionality of the stents is determined by geometrical variability of the scaffolding and concomitant interstices.
  • Stents are devices that are inserted into a vessel or passage to keep the lumen open and prevent closure due to a stricture, external compression, or internal obstruction.
  • stents are commonly used to keep blood vessels open in the coronary arteries and they are frequently inserted into the ureters to maintain drainage from the kidneys, the bile duct for pancreatic cancer or cholangiocarcinoma or the esophagus for strictures or cancer.
  • vascular as well as not vascular stenting has evolved significantly; unfortunately there remain significant limitations with respect to the technology for producing stents suitable to various portions of a patient's anatomy.
  • the stent had to be manufactured from multiple materials, at least one for each characteristic desired. As a result, many of these stents are woven from two or more metals having differing shape-memories for example. Unfortunately, braided stents are vulnerable to premature obsolescence. Moreover, providing multiple material types in a single stent may lead to inconsistent characteristics along the surface area of the stent. This is particularly undesirable when the stent is to be placed in vascular or nonvascular lumens that have been occluded for one reason or another. The stent needs to be stiffer in some regions while more flexible in others.
  • a therapeutic stent that can have varying characteristics along its surface area while being stamped, not braded, from a single base material.
  • a therapeutic stent where the relative hardness, softness, flexibility, stiffness and radial force can be modified as a function of geometric considerations rather than material considerations.
  • a stent that is divided into zones so as to allow the stent to have predetermined characteristics in one zone and could conceivably have drastically different characteristics in an adjacent zone so as to allow for stents that can be tailored to anatomical lumens in general and the particular lumen topography of a specific patient in particular.
  • a principal purpose of the present invention to provide a stent, in accordance with an exemplary embodiment of the present invention, which combines many of the excellent characteristics of both silicone and metal stents while eliminating the undesirable ones.
  • it is an objective of a preferred embodiment in accordance with the present invention to provide a stent that is easily installed, yet in alternative embodiments, removable.
  • the stent in accordance with this embodiment of the present invention would not cause material infections and may be capable of reducing infection. Therefore, a principal objective of a preferred embodiment in accordance with the present invention is to provide a prosthesis that is suitable for both permanent and temporary use while being easy to insert, reposition and remove.
  • a principal objective of a preferred embodiment of the present invention is to provide a stent that may be stamped from preferably a single material that is capable of maintaining its axial working length when radially compressed. To this end, the stent does not have a seam that could aggravate luminal tissue.
  • a stent in accordance with the present invention is formed using a tool that molds the stents outer contour as well as its interstices.
  • Still another objective of the present invention is to provide a stent and method for installing the stent that is economical and suitable for routine purposes. Moreover, the stent will have minimal migration, cause minimal tissue granulation, will not foreshorten after deployment and mucociliary clearance will not be problematic.
  • Yet another objective of an exemplary embodiment in accordance with the present invention is to provide a prosthesis that will have superior internal to external diameter ratio, superior radial force with dynamic expansion, while being suitable for use in pediatric and adult patients with malignant and benign disease.
  • a principal objective of an exemplary stent in accordance with the present invention is to provide a family of stents where the relative hardness/softness of regions of the stent can differ from other regions of the stent to provide additional patient comfort and resistance to radial forces.
  • An additional objective in accordance with an exemplary embodiment is to provide a family of stents with novel interstice configurations that facilitate flexibility, durability and/or proper installation.
  • Still another objective of a preferred embodiment of the present invention is to provide a self-expanding stent have the above benefits that also defines a plurality of apertures at the termini of the stent for, inter alia, removal of the stent.
  • FIG. 1 shows a side perspective view of an exemplary stent in accordance with the present invention.
  • FIG. 2 shows a side perspective view of a single zone of the stent shown in FIG. 1 .
  • FIG. 3 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 .
  • FIG. 4 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative octagonal connection member.
  • FIG. 5 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative omega shaped connection member.
  • FIG. 6 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative M shaped connection member.
  • FIG. 7 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative S shaped connection member.
  • FIG. 8 shows a magnified view of the scaffolding and interstice topology of the medical appliance shown in FIG. 1 .
  • FIG. 9 shows a magnified portion of the scaffolding and interstice topology of the medical appliance of FIG. 1 , showing how modifications in geometric dimensions affect functionality.
  • FIG. 10 shows an enlarged perspective view of an exemplary connector wherein the connector is oriented closer to one zone than another.
  • FIG. 11 shows an enlarged perspective view of an exemplary connector wherein the connector is oriented closer to the opposite zone as the connector shown in FIG. 10 .
  • FIG. 12 shows an enlarged perspective view of an exemplary connector wherein the connector is oriented substantially equidistant between two zones.
  • a preferred embodiment of the stent in accordance with the present invention, provides a stent that prevents epithelialization of the stent and is not subject to premature elongation and foreshortening but is capable of engaging the desired implantation location.
  • the stent also retains its axial length while undergoing radial compression.
  • the stent is preferably formed from a composite material selected from the group consisting essentially of Ni, C, Co, Cu, Cr, H, Fe, Nb, O, Ti and combinations thereof.
  • the composite material is generally formed into a compressed tube from which the stent is etched and is formed on a suitable shaping device to give the stent the desired external geometry.
  • stents in accordance with the present invention can take on an infinite number of characteristic combinations as zones and segments within a zone can be modified by changing angles, segment lengths and segment thicknesses during the etching and forming stages of stent engineering or during post formation processing and polishing steps. Moreover, by modifying the geometry of the connectors between zones, addition functionality may be achieved.
  • Exemplary stents 10 in accordance with the present invention are shown in FIGS. 1-3 showing the preferred interstice geometry. Not shown are a wide variety of interstice geometries that are also acceptable alternatives to the preferred, namely, U, V, W, Z, S and X geometries to name a few.
  • the stent 10 also is formed of memory metal and preferably has unique geometrical interstices that are laser etched therein. However, other conventional ways of forming interstices in unitary stents, though not equivalent are contemplated, may be employed and would be within the skill set of one in the art.
  • the substantially U-shape connector comprises preferably two leg members 52 & 56 and a crossing member 54 that connects with and extends perpendicularly at preferably 90° angles with respect to the leg members 52 & 56 .
  • a crossing member 54 that connects with and extends perpendicularly at preferably 90° angles with respect to the leg members 52 & 56 .
  • alternative angles may be provided without departing materially from the invention.
  • the present inventors discovered that if you modify the length of the crossing member 54 and/or the leg members 52 & 56 and/or the angle ⁇ at which the crossing member 54 and the leg members 52 & 56 intersect, the relative hardness/softness, radial force and/or flexibility of the stent 10 could be modified.
  • the angles ⁇ can be modified at varying acute angles short of 90° or varying obtuse angles greater than 90°.
  • the incremental changes correspondingly change certain characteristics of the stent 10 .
  • different zones of the stent 10 can be given different rigidities to improve patient comfort and for example, in airway stents, to facilitate luminal patency.
  • various anatomical lumens may need different degrees of stent rigidity.
  • stents 10 in accordance with the present invention can be manufactured to exacting specifications to contour properly to various lumens in a patient's anatomy, which may need varying levels of structural support from the medical appliance.
  • the behavior is a function of distance and as a result varies along a continuum with respect to the connector's orientation between the medium between zones and the tip of each zone.
  • functionality can be impacted.
  • the fewer the number of connectors connecting the zones the more torsional flexibility the stent will have.
  • the converse will generally hold true with respect to a greater number of connectors.
  • each arrow shaped band preferably comprises a forward angle ⁇ and a rear angle ⁇ .
  • the forward angle ⁇ is formed by the intersection of two legs 24 & 25 .
  • Legs 24 & 25 connect at first ends 26 & 27 to form the head 22 of angle ⁇ .
  • Second ends 28 & 29 of legs 24 & 25 terminate at connectors 40 .
  • Connector 40 connects the legs 24 & 25 of forward angle ⁇ to the legs 32 & 34 of rear angle ⁇ via intermediary leg 36 .
  • legs 32 , 34 & 36 connect is the head 30 , which defines an aperture 38 for installing suture.
  • the modification of interstice geometries and manipulation of the U shaped connection member to achieve variable stent functionality is provided.
  • the rigidity of the stent scaffolding or interstice matrix along with the torsionality of the stent itself is principally a function of these modifications.
  • the stents relative flexibility can be rated soft, medium or hard based on the degree of flex and torsionality. The less torsionality and flex in the stent the harder the stent is rated.
  • An exemplary stent in accordance with the present invention with relatively great torsionality and radial flexibility would be rated soft.
  • An exemplary soft rated stent comprises distance between U shaped connectors of about 4.5 ⁇ m in the compressed state (i.e., contracted in the 3 mm tube subject to laser etching).
  • the length of the crossing member is preferably about 1.0 ⁇ m.
  • the lengths of the leg members are preferably about 1.5 ⁇ m in length.
  • the leg members may further comprise feet that attached to the remainder of the stent scaffolding. The feet can be adjusted from a standard length of about 0.25 ⁇ m to further adjust the characteristics of the stent.
  • the softness index or relative flexibility can be increase by increasing the various lengths discussed above. For example, by increasing the length of the legs and crossing members of the U shaped connector, flexibility increases.
  • This relative softness/hardness indexing as a corollary of interstice dimensions is a novel aspect of preferred embodiment of the present invention. As a practical rule of thumb, longer leg lengths coupled with acute angles provide for greater flexibility. Conversely, shorter leg lengths and more obtuse angles provide more rigidity.
  • a U shaped connector with short legs deviating from the crossing member at angles greater than 90° will be extremely rigid and resistant to torsional strain as compared to a U shaped connector with longer legs diverging from the crossing member at angles less than 90°.

Abstract

The present invention, in an exemplary embodiment, provides a stent, which combines many of the excellent characteristics of both silicone and metal stents while eliminating the undesirable ones. In particular, a principal objective in accordance with the present invention is to provide a family of stents where the relative hardness/softness of regions of the stent can differ from other regions of the stent to provide additional patient comfort and resistance to radial forces. An exemplary embodiment also provides a family of stents with novel interstice configurations that facilitate flexibility, durability and/or proper installation.

Description

FIELD OF INVENTION
The present invention relates generally to medical devices directed to the prevention of luminal occlusion, and more particularly to stents and methods for making and utilizing these stents in the treatment of both benign and malignant conditions wherein the functionality of the stents is determined by geometrical variability of the scaffolding and concomitant interstices.
BACKGROUND OF THE INVENTION
Stents are devices that are inserted into a vessel or passage to keep the lumen open and prevent closure due to a stricture, external compression, or internal obstruction. In particular, stents are commonly used to keep blood vessels open in the coronary arteries and they are frequently inserted into the ureters to maintain drainage from the kidneys, the bile duct for pancreatic cancer or cholangiocarcinoma or the esophagus for strictures or cancer. Vascular as well as not vascular stenting has evolved significantly; unfortunately there remain significant limitations with respect to the technology for producing stents suitable to various portions of a patient's anatomy.
Historically, in order to provide a stent with varying characteristics, the stent had to be manufactured from multiple materials, at least one for each characteristic desired. As a result, many of these stents are woven from two or more metals having differing shape-memories for example. Unfortunately, braided stents are vulnerable to premature obsolescence. Moreover, providing multiple material types in a single stent may lead to inconsistent characteristics along the surface area of the stent. This is particularly undesirable when the stent is to be placed in vascular or nonvascular lumens that have been occluded for one reason or another. The stent needs to be stiffer in some regions while more flexible in others. Therefore, there remains an existing need for a therapeutic stent that can have varying characteristics along its surface area while being stamped, not braded, from a single base material. Moreover, there is a need for such a therapeutic stent where the relative hardness, softness, flexibility, stiffness and radial force can be modified as a function of geometric considerations rather than material considerations. In particular, there is a need for a stent that is divided into zones so as to allow the stent to have predetermined characteristics in one zone and could conceivably have drastically different characteristics in an adjacent zone so as to allow for stents that can be tailored to anatomical lumens in general and the particular lumen topography of a specific patient in particular.
SUMMARY OF EXEMPLARY EMBODIMENTS
It is a principal purpose of the present invention to provide a stent, in accordance with an exemplary embodiment of the present invention, which combines many of the excellent characteristics of both silicone and metal stents while eliminating the undesirable ones. In particular, it is an objective of a preferred embodiment in accordance with the present invention to provide a stent that is easily installed, yet in alternative embodiments, removable. Moreover the stent in accordance with this embodiment of the present invention would not cause material infections and may be capable of reducing infection. Therefore, a principal objective of a preferred embodiment in accordance with the present invention is to provide a prosthesis that is suitable for both permanent and temporary use while being easy to insert, reposition and remove.
A principal objective of a preferred embodiment of the present invention is to provide a stent that may be stamped from preferably a single material that is capable of maintaining its axial working length when radially compressed. To this end, the stent does not have a seam that could aggravate luminal tissue. In particular, a stent in accordance with the present invention is formed using a tool that molds the stents outer contour as well as its interstices.
It is yet another objective of an exemplary embodiment of the present invention to provide a stent that can be indicated for the treatment of benign and malignant disease and improve the way clinicians treat malignant obstructions.
Still another objective of the present invention is to provide a stent and method for installing the stent that is economical and suitable for routine purposes. Moreover, the stent will have minimal migration, cause minimal tissue granulation, will not foreshorten after deployment and mucociliary clearance will not be problematic.
Yet another objective of an exemplary embodiment in accordance with the present invention is to provide a prosthesis that will have superior internal to external diameter ratio, superior radial force with dynamic expansion, while being suitable for use in pediatric and adult patients with malignant and benign disease.
A principal objective of an exemplary stent in accordance with the present invention is to provide a family of stents where the relative hardness/softness of regions of the stent can differ from other regions of the stent to provide additional patient comfort and resistance to radial forces.
An additional objective in accordance with an exemplary embodiment is to provide a family of stents with novel interstice configurations that facilitate flexibility, durability and/or proper installation.
Still another objective of a preferred embodiment of the present invention is to provide a self-expanding stent have the above benefits that also defines a plurality of apertures at the termini of the stent for, inter alia, removal of the stent.
Further objectives, features and advantages of the invention will be apparent from the following detailed description taken in conjunction with the accompanying drawings.
BRIEF DESCRIPTION OF THE FIGURES
FIG. 1 shows a side perspective view of an exemplary stent in accordance with the present invention.
FIG. 2 shows a side perspective view of a single zone of the stent shown in FIG. 1.
FIG. 3 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2.
FIG. 4 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative octagonal connection member.
FIG. 5 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative omega shaped connection member.
FIG. 6 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative M shaped connection member.
FIG. 7 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative S shaped connection member.
FIG. 8 shows a magnified view of the scaffolding and interstice topology of the medical appliance shown in FIG. 1.
FIG. 9 shows a magnified portion of the scaffolding and interstice topology of the medical appliance of FIG. 1, showing how modifications in geometric dimensions affect functionality.
FIG. 10 shows an enlarged perspective view of an exemplary connector wherein the connector is oriented closer to one zone than another.
FIG. 11 shows an enlarged perspective view of an exemplary connector wherein the connector is oriented closer to the opposite zone as the connector shown in FIG. 10.
FIG. 12 shows an enlarged perspective view of an exemplary connector wherein the connector is oriented substantially equidistant between two zones.
DETAILED DESCRIPTION OF AN EMBODIMENT
A preferred embodiment of the stent, in accordance with the present invention, provides a stent that prevents epithelialization of the stent and is not subject to premature elongation and foreshortening but is capable of engaging the desired implantation location. The stent also retains its axial length while undergoing radial compression.
The stent is preferably formed from a composite material selected from the group consisting essentially of Ni, C, Co, Cu, Cr, H, Fe, Nb, O, Ti and combinations thereof. The composite material is generally formed into a compressed tube from which the stent is etched and is formed on a suitable shaping device to give the stent the desired external geometry. Both the synthetic collar techniques and in vitro valuation techniques show the remarkable ability of stents in accordance with the present invention to convert acting force into deformation work absorbed by the angled structure, which prevents excessive scaffolding stress and premature material fatigue and accelerated obsolescence.
Though one skilled in the stent engineering art, once apprised of the present application, would be able to manufacture a stent consistent with the present invention by other methods, a preferred method of manufacturing such stents follows. As stated above a composite material is selected and a blank is formed there from. The blank is preferably laser etched and the etch work is generally verified for accuracy using visual recording microscopy. Dimensional measurements are taken to ensure strut thickness, segment angles, zone placement, etc. Moreover, the stent is preferably formed on a shaping tool that has substantially the desired contour of the external stent dimensions.
In the event the stent is to be shaped to the dimensions of a particular lumen, optical photography and/or optical videography of the target lumen may be conducted prior to stent formation. The geometry of corresponding zones and connector regions of the stent then can be etched and formed in accordance with the requirements of that target lumen. For example, if the stent were designed for the trachea, which has a substantially D shaped lumen and additionally the middle zones needed to be softer than the end zones, the stent could be designed to those specifications. In particular, if the topography of the trachea of a particular patient is captured optically and the appropriate dimension provided, a patient specific prosthesis could be engineered. These techniques can be adapted to other non-vascular lumen but is very well suited for vascular applications where patient specific topography is a function of a variety of factors such as genetics, lifestyle, etc.
It should be pointed out that unlike the use of differing shape memory materials to change regions of a stent, stents in accordance with the present invention can take on an infinite number of characteristic combinations as zones and segments within a zone can be modified by changing angles, segment lengths and segment thicknesses during the etching and forming stages of stent engineering or during post formation processing and polishing steps. Moreover, by modifying the geometry of the connectors between zones, addition functionality may be achieved.
Exemplary stents 10 in accordance with the present invention are shown in FIGS. 1-3 showing the preferred interstice geometry. Not shown are a wide variety of interstice geometries that are also acceptable alternatives to the preferred, namely, U, V, W, Z, S and X geometries to name a few.
The stent 10 also is formed of memory metal and preferably has unique geometrical interstices that are laser etched therein. However, other conventional ways of forming interstices in unitary stents, though not equivalent are contemplated, may be employed and would be within the skill set of one in the art.
It cannot be overemphasized, however, that this does not mean the knowledge that changes in the geometry of interstices affect stent functionality is currently known in the art. To the contrary, the present inventors discovered the interrelation between interstice geometry, width, length and relative resistance to torsional stress and radial force. In fact, it can be said that the stent 10 has circumferential bands extending perpendicularly with respect to the luminal device's longitudinal axis. These bands are referred to generally as zones. A connector 50 connects these bands to one another; the connector 50 is an additional means for adjusting stent functionality. In particular, the connector 50 defines a substantially U shaped member, but could define other geometries such as U, V, W, Z, S and X to name a few.
In a standard orientation, as shown particularly in FIG. 1, the substantially U-shape connector comprises preferably two leg members 52 & 56 and a crossing member 54 that connects with and extends perpendicularly at preferably 90° angles with respect to the leg members 52 & 56. It must be noted that alternative angles may be provided without departing materially from the invention. The present inventors discovered that if you modify the length of the crossing member 54 and/or the leg members 52 & 56 and/or the angle γ at which the crossing member 54 and the leg members 52 & 56 intersect, the relative hardness/softness, radial force and/or flexibility of the stent 10 could be modified. The angles γ can be modified at varying acute angles short of 90° or varying obtuse angles greater than 90°. The incremental changes correspondingly change certain characteristics of the stent 10. As a result, different zones of the stent 10 can be given different rigidities to improve patient comfort and for example, in airway stents, to facilitate luminal patency. Moreover, various anatomical lumens may need different degrees of stent rigidity. As a result, stents 10 in accordance with the present invention can be manufactured to exacting specifications to contour properly to various lumens in a patient's anatomy, which may need varying levels of structural support from the medical appliance.
As depicted in FIGS. 10-12, by adjusting the distance between the connector 50 and for examples Zones 2 and 3 between which connector 50 resides, the way in which the stent reacts to strain can be modified. By way of non-limiting example, if the connector 40 is oriented closer to zone 3 than to zone 2, the stent will be less flexible and be able to withstand greater radial force. Alternatively, if the connector is equidistant between Zones 2 and 3, the stent will be more flexible and be able to withstand less radial force. Please note that these differences are relative to a neutrally located connector 40. The behavior is a function of distance and as a result varies along a continuum with respect to the connector's orientation between the medium between zones and the tip of each zone. Moreover, within by varying the number of connectors 40 that connect the zones to one another, functionality can be impacted. In particular, the fewer the number of connectors connecting the zones the more torsional flexibility the stent will have. The converse will generally hold true with respect to a greater number of connectors.
Referring now to FIG. 2, stent 10 is shown having several bands within a zone forming substantially arrow shaped regions. In particular, each arrow shaped band preferably comprises a forward angle β and a rear angle α. The forward angle β is formed by the intersection of two legs 24 & 25. Legs 24 & 25 connect at first ends 26 & 27 to form the head 22 of angle β. Second ends 28 & 29 of legs 24 & 25 terminate at connectors 40. Connector 40 connects the legs 24 & 25 of forward angle β to the legs 32 & 34 of rear angle α via intermediary leg 36. Where legs 32, 34 & 36 connect is the head 30, which defines an aperture 38 for installing suture.
Connector 40, which serves a similar purpose as connector 50 also has a crossing member 44 that connects leg members 42 & 46 at a predetermined angle δ. As discussed above, since form follows function for stents prepared through this novel method, by changing the degrees of angles α, β, δ & γ, stent characteristics can be modified. Moreover, by changing the leg lengths of all the previously discussed legs or individual legs separately, additional stent characteristics can be obtained. The beauty of this system is that the desired characteristics can be determined prior to forming the stent and by staying within certain forming parameters, the stent can be formed, crimped, delivered and deployed with confidence that the desired functionality with result. This is important in light of the fact that both vascular and nonvascular lumen have unique topography. As a result, methods and devices in accordance with the present invention usher in the ability to tailor prosthesis to anatomical tissue in general and particular patient anatomy in particular.
The U shaped connectors 40 & 50 have a crossing member and at least two leg members, respectively. The present inventors discovered that if you increase/decrease the length of leg members and/or increase/decrease the length of crossing members and/or vary the angle at which crossing members and leg members intersect, you affect the functionality of the stent. In particular, the shorter the length of the leg members, the less flexibility available in that portion of the stent. Taking particular note of FIG. 3, by way of example only, if you want to decrease the amount of torsional flexibility of the stent 10, you would have to modify the connector 40 so that the legs 42 & 46 are longer than shown and that the angle δ formed by legs 42 & 46 and crossing member 44, respectively, is slightly greater than 90°. Alternatively, the length of the crossing member 44 can impact the functionality of the stent as well. The stent can be made more rigid by shortening crossing member 44 or the stent may be made more flexible by lengthening crossing member 44. It should be noted that the combination of the changes of leg lengths, crossing member lengths, angle variations, shapes and number of connectors provide the stent with the ability to conform to specific lumens in the anatomy of a patient. The result is a form fitting medical prosthesis that may be tailored to specific anatomical lumens in general and to the anatomical lumens of an individual patient in particular.
In a preferred embodiment, the modification of interstice geometries and manipulation of the U shaped connection member to achieve variable stent functionality is provided. The rigidity of the stent scaffolding or interstice matrix along with the torsionality of the stent itself is principally a function of these modifications. In an exemplary embodiment, the stents relative flexibility can be rated soft, medium or hard based on the degree of flex and torsionality. The less torsionality and flex in the stent the harder the stent is rated.
An exemplary stent in accordance with the present invention with relatively great torsionality and radial flexibility would be rated soft. An exemplary soft rated stent comprises distance between U shaped connectors of about 4.5 μm in the compressed state (i.e., contracted in the 3 mm tube subject to laser etching). Moreover, the length of the crossing member is preferably about 1.0 μm. The lengths of the leg members are preferably about 1.5 μm in length. Additionally the leg members may further comprise feet that attached to the remainder of the stent scaffolding. The feet can be adjusted from a standard length of about 0.25 μm to further adjust the characteristics of the stent. There is additionally a substantially rectangular member incorporated in the U shaped connector with similar capacity for variability. The variability factors and results of modifying the dimensions of the substantially rectangular members are similar to those evinced by leg length dimensional modifications.
Referring now to FIGS. 8 and 9, where like numerals refer to like parts, luminal stent 810 is shown having substantially U shaped connectors 818 having a crossing member 819 a and at least two leg members 819 b-c respectively. The present inventors discovered that if you increase/decrease the length of leg member 819 b and/or 819 c, increase/decrease the length of crossing member 819 a, and/or vary the angle at which crossing member 819 a and leg members 819 b-c intersect, you affect the functionality of the stent. In particular, the shorter the length of leg members 819 a-b the less flexibility available in that portion of the stent. Taking particular note of FIG. 9, by way of example only, if you want to decrease the amount of torsional flexibility of the luminal stent 910, you would have to modify the desired portion of the stent to resemble 918 f. However, if you want a stiffer appliance 910, you would have a configuration analogous to that of 918 a.
By way of example, but not to be construed in any way as limiting, the softness index or relative flexibility can be increase by increasing the various lengths discussed above. For example, by increasing the length of the legs and crossing members of the U shaped connector, flexibility increases. However, with respect to the distance between U shaped members and distance between interstices in a preferred stent embodiment, there is an inverse correlation between length and softness. This relative softness/hardness indexing as a corollary of interstice dimensions is a novel aspect of preferred embodiment of the present invention. As a practical rule of thumb, longer leg lengths coupled with acute angles provide for greater flexibility. Conversely, shorter leg lengths and more obtuse angles provide more rigidity. By way of non-limiting example, a U shaped connector with short legs deviating from the crossing member at angles greater than 90°, will be extremely rigid and resistant to torsional strain as compared to a U shaped connector with longer legs diverging from the crossing member at angles less than 90°.
In addition to the length and spacing differences, the interstices themselves may define various shapes that by their very nature afford novel functionality to the stent. The changes of functionality, however, are more a function of the dimensional differences of the various shapes rather than a function of the shapes themselves. Therefore, it is important to keep in mind that the dimensional differences discussed in the previous paragraph are determinative of the functionality accorded the stent by the varying interstice geometries. It is for this reason that one of ordinary skill in the art, after being apprised of the present invention, would be able to conceive of a number of interstice geometries to satisfy certain functionality criteria by keeping certain dimensional parameters constant.
The present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative, and not restrictive. The scope of the invention is, therefore, indicated by the appended claims, rather than by the foregoing description. All changes, which come within the meaning and range of equivalency of the claims, are to be embraced within their scope.

Claims (38)

1. A medical appliance for placement within a portion of the anatomy of a patient, the appliance comprising:
a scaffolding, the scaffolding configured to define a substantially cylindrical member having a distal end and a proximal end and extending longitudinally there between, forming a lumen there through, such that when pressure is exerted along varying points of the longitudinal extension of the appliance, the appliance does not undesirably foreshorten or elongate
said scaffolding including:
a plurality of expandable circumferential bands, each of the circumferential bands having a plurality of angularly extending legs with interconnected ends defining a plurality of peaks and valleys, wherein the legs have approximately equal lengths within each of the circumferential bands, and
a plurality of connectors coupled to respective peaks and/or valleys of each adjacent pair of the circumferential bands, each of the connectors including a flexible portion that is configured to be positioned between peaks and/or valleys of adjacent ones of the circumferential bands when the scaffolding is compressed, wherein each flexible portion includes a pair of connector leg members and a crossing member that connects the leg members at a predetermined angle, and wherein the peaks of at least two adjacent circumferential bands are connected by the connectors extending therebetween to define a plurality of arrow shaped regions.
2. The medical appliance of claim 1, wherein along the longitudinal extension of the appliance, the scaffolding forms geometrical patterns.
3. The medical appliance of claim 2, wherein the scaffolding further comprises a coating coupled with the scaffolding, the coating of sufficient thickness to prevent the medical appliance from becoming epithelialized when installed in the desired portion of the patient's anatomy.
4. The medical appliance of claim 3, wherein the coating does not inhibit flexing or radial expansion of the medical appliance.
5. The medical appliance of claim 4, wherein the coating is coupled with the medical appliance about the proximal and distal ends thereof.
6. The medical appliance of claim 2, wherein the dimensions of the scaffolding geometry determine torsionality of the medical appliance.
7. The medical appliance of claim 2, wherein the geometrical patterns are substantially U-shaped.
8. The medical appliance of claim 1, wherein the scaffolding is formed of a memory capable alloy.
9. The medical appliance of claim 8, wherein the scaffolding is electro polished.
10. The medical appliance of claim 1, wherein near the distal and proximal ends of the scaffolding the medical appliance further comprise a plurality of flanges that define apertures there through.
11. The medical appliance of claim 1, wherein the flexible portion further comprises a rectangular detent extending from a connector leg thereof.
12. The medical appliance of claim 1, wherein the length of the connector leg members and the degree of the angle at which the connector legs extend from the crossing member determines the relative flexibility of the medical appliance.
13. The medical appliance of claim 12, wherein the angle at which the connector leg members extend from the crossing member is 90° or less.
14. The medical appliance of claim 13, wherein the medical appliance is relatively flexible.
15. The medical appliance of claim 1, further comprising an additional distal end wherein the medical appliance forms a substantially Y-shape.
16. The medical appliance of claim 15, wherein along the longitudinal extension of the appliance, the scaffolding forms geometrical patterns.
17. The medical appliance of claim 16, wherein the scaffolding further comprises a coating coupled with the scaffolding, the coating of sufficient thickness to prevent the medical appliance from becoming epithelialized when installed in the desired portion of the patient's anatomy.
18. The medical appliance of claim 17, wherein the dimensions of the scaffolding geometry determine torsionality of the medical appliance.
19. The medical appliance of claim 18, wherein the scaffolding is electropolished.
20. The medical appliance of claim 17, wherein the scaffolding is formed of a memory capable alloy.
21. The medical appliance of claim 17, wherein near the distal and proximal ends of the scaffolding the medical appliance further comprise a plurality of flanges that define apertures there through.
22. The medical appliance of claim 15, wherein the connector includes a crossing member and a plurality of connector leg members extending from the crossing member.
23. The medical appliance of claim 22, wherein the connector further comprises a rectangular detent extending from a connector leg thereof.
24. The medical appliance of claim 22, wherein the length of the connector leg members or the degree of the angle at which the connector legs extend from the crossing member positively contributes to the relative flexibility of the medical appliance.
25. The medical appliance of claim 24, wherein the angle at which the connector leg members extend from the crossing member is 90° or less.
26. The medical appliance of claim 25, wherein the medical appliance is relatively flexible.
27. The medical appliance of claim 15, wherein the geometrical patterns are substantially U-shaped.
28. The medical appliance of claim 1, wherein at least two circumferential bands include at least some connectors that connect the peak of one of the circumferential bands with the valley of an adjacent one of the circumferential bands.
29. The medical appliance of claim 28, wherein each of the connectors includes at least one straight longitudinal portion that extends from the flexible portion, between adjacent legs of the adjacent one of the circumferential bands, and connects to the valley.
30. The medical appliance of claim 28, wherein the plurality of arrow shaped regions are located at the proximal or distal ends of the scaffolding, and wherein the at least two circumferential bands having connectors connecting the peaks and valleys are located at an end of the scaffolding opposite that of the arrow shaped regions.
31. The medical appliance of claim 1, wherein said flexible portion extends circumferentially to abut a circumferentially adjacent flexible portion.
32. A method of treating a patient suffering from luminal irregularities, comprising the steps of:
providing a medical appliance comprising a scaffolding, the scaffolding configured to define a substantially cylindrical member having a distal end and a proximal end and extending longitudinally there between, forming a lumen there through, along the longitudinal extension of the appliance the scaffolding forms geometrical patterns formed by angles, wherein the angles determine the relative flexibility of the medical appliance such that the appliance conforms to the topography of a target lumen and when pressure is exerted along varying points of the longitudinal extension of the appliance, the appliance does not undesirably foreshorten or elongate,
said scaffolding including:
a plurality of expandable circumferential bands, each of the circumferential bands having a plurality of angularly extending legs with interconnected ends defining a plurality of peaks and valleys, wherein the legs have approximately equal lengths within each of the circumferential bands, and
a plurality of connectors coupled to respective peaks and/or valleys of each adjacent pair of the circumferential bands, each of the connectors including a flexible portion that is configured to be positioned between peaks and/or valleys of adjacent ones of the circumferential bands when the scaffolding is compressed, wherein each flexible portion includes a pair of connector leg members and a crossing member that connects the leg members at a predetermined angle, and wherein the peaks of at least two adjacent circumferential bands are connected by the connectors extending therebetween to define a plurality of arrow shaped regions;
installing the medical appliance in a preferred location of the anatomy of the patient; and
activating the expansion of the medical appliance in the desired location.
33. The method of claim 32, wherein the preferred location is a non-vascular lumen.
34. The method of claim 33, further comprising the step of removing the medical appliance from the anatomy of the patient.
35. The method of claim 33, wherein the medical appliance further comprises anti-microbial agents coupled therewith.
36. The method of claim 33, wherein the medical appliance further comprises chemotherapeutic agents coupled therewith.
37. The medical appliance of claim 32, further comprising an additional distal end wherein the medical appliance forms a substantially Y-shape.
38. A medical appliance comprising:
a plurality of expandable circumferential bands, each of the circumferential bands having a plurality of angularly extending legs with interconnected ends defining a plurality of peaks and valleys, wherein the legs have approximately equal lengths within each of the circumferential bands; and
a plurality of connectors coupled to respective peaks and/or valleys of each adjacent pair of the circumferential bands, each of the connectors including a flexible portion that is configured to be positioned between peaks and/or valleys of adjacent ones of the circumferential bands when the medical appliance is compressed,
wherein said flexible portion is further configured to extend circumferentially to abut a circumferentially adjacent flexible portion when the medical appliance is compressed, and wherein each flexible portion includes a pair of connector leg members and a crossing member that connects the leg members at a predetermined angle, and wherein the peaks of at least two adjacent circumferential bands are connected by the connectors extending therebetween to define a plurality of arrow shaped regions.
US10/288,615 2002-11-05 2002-11-05 Stent with geometry determinated functionality and method of making the same Expired - Lifetime US7527644B2 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
US10/288,615 US7527644B2 (en) 2002-11-05 2002-11-05 Stent with geometry determinated functionality and method of making the same
US10/669,450 US7637942B2 (en) 2002-11-05 2003-09-24 Coated stent with geometry determinated functionality and method of making the same
US10/674,972 US7875068B2 (en) 2002-11-05 2003-09-30 Removable biliary stent
EP03776570A EP1558178B1 (en) 2002-11-05 2003-10-27 Stent with geometry determinated functionality and method of making the same
JP2004551583A JP4431046B2 (en) 2002-11-05 2003-10-27 Stent with functionality determined by deployment configuration
AU2003284180A AU2003284180B2 (en) 2002-11-05 2003-10-27 Stent with geometry determinated functionality and method of making the same
PCT/US2003/034075 WO2004043221A2 (en) 2002-11-05 2003-10-27 Stent with geometry determinated functionality and method of making the same
DE60328507T DE60328507D1 (en) 2002-11-05 2003-10-27 STENT WITH FUNCTIONALITY DETERMINED BY GEOMETRY AND METHOD OF MANUFACTURE
CA002505121A CA2505121A1 (en) 2002-11-05 2003-10-27 Stent with geometry determinated functionality and method of making the same
US10/718,217 US7959671B2 (en) 2002-11-05 2003-11-20 Differential covering and coating methods
PCT/US2004/039162 WO2005110282A1 (en) 2002-11-05 2004-11-20 Differential covering and coating methods
US12/616,455 US8206436B2 (en) 2002-11-05 2009-11-11 Coated stent with geometry determinated functionality and method of making the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/288,615 US7527644B2 (en) 2002-11-05 2002-11-05 Stent with geometry determinated functionality and method of making the same

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US10/669,450 Continuation-In-Part US7637942B2 (en) 2002-11-05 2003-09-24 Coated stent with geometry determinated functionality and method of making the same
US10/674,972 Continuation-In-Part US7875068B2 (en) 2002-11-05 2003-09-30 Removable biliary stent
US10/718,217 Continuation-In-Part US7959671B2 (en) 2002-11-05 2003-11-20 Differential covering and coating methods

Publications (2)

Publication Number Publication Date
US20040088040A1 US20040088040A1 (en) 2004-05-06
US7527644B2 true US7527644B2 (en) 2009-05-05

Family

ID=32175926

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/288,615 Expired - Lifetime US7527644B2 (en) 2002-11-05 2002-11-05 Stent with geometry determinated functionality and method of making the same

Country Status (7)

Country Link
US (1) US7527644B2 (en)
EP (1) EP1558178B1 (en)
JP (1) JP4431046B2 (en)
AU (1) AU2003284180B2 (en)
CA (1) CA2505121A1 (en)
DE (1) DE60328507D1 (en)
WO (1) WO2004043221A2 (en)

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090281615A1 (en) * 2008-05-08 2009-11-12 Boston Scientific Scimed, Inc. Stent with tabs and holes for drug delivery
US20110046710A1 (en) * 2009-08-24 2011-02-24 Qualimed Gmbh Implantation device with handle and method of use thereof
WO2013172938A1 (en) * 2012-05-14 2013-11-21 C.R. Bard, Inc. Uniformly expandable stent
US20140356407A1 (en) * 2012-03-09 2014-12-04 Q3 Medical Devices Limited Biodegradable supporting device
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
US9381103B2 (en) * 2014-10-06 2016-07-05 Abbott Cardiovascular Systems Inc. Stent with elongating struts
US9393139B2 (en) 2009-08-24 2016-07-19 Qualimed Innovative Medizinprodukte Gmbh Implantation system with handle and catheter and method of use thereof
US20160302947A1 (en) * 2006-10-06 2016-10-20 Abbott Cardiovascular Systems Inc. Intravascular stent
US9700401B2 (en) 2013-09-12 2017-07-11 Boston Scientific Scimed, Inc. Stent with anti-migration connectors
US9907684B2 (en) 2013-05-08 2018-03-06 Aneuclose Llc Method of radially-asymmetric stent expansion
US9999531B2 (en) 2009-08-24 2018-06-19 Qualimed Innovative Medizinprodukte Gmbh Variable scale stent deployment device
US10117763B2 (en) 2014-03-18 2018-11-06 Boston Scientific Scimed, Inc. Reduced granulation and inflammation stent design
US10130498B2 (en) 2014-10-22 2018-11-20 Boston Scientific Scimed, Inc. Stent with flexible hinge
US10219921B2 (en) 2014-10-02 2019-03-05 Boston Scientific Scimed, Inc. Controlled ingrowth feature for antimigration
US10271975B2 (en) 2013-03-15 2019-04-30 Atrium Medical Corporation Stent device having reduced foreshortening and recoil and method of making same
US10271977B2 (en) 2017-09-08 2019-04-30 Vesper Medical, Inc. Hybrid stent
US10500078B2 (en) 2018-03-09 2019-12-10 Vesper Medical, Inc. Implantable stent
US10596660B2 (en) 2015-12-15 2020-03-24 Howmedica Osteonics Corp. Porous structures produced by additive layer manufacturing
US10702405B2 (en) 2016-03-31 2020-07-07 Vesper Medical, Inc. Intravascular implants
US10849769B2 (en) 2017-08-23 2020-12-01 Vesper Medical, Inc. Non-foreshortening stent
US10888362B2 (en) 2017-11-03 2021-01-12 Howmedica Osteonics Corp. Flexible construct for femoral reconstruction
US10898354B2 (en) 2014-11-06 2021-01-26 Boston Scientific Scimed, Inc. Tracheal stent
US11344307B2 (en) * 2014-05-02 2022-05-31 W. L. Gore & Associates, Inc. Anastomosis devices
US11357650B2 (en) 2019-02-28 2022-06-14 Vesper Medical, Inc. Hybrid stent
US11364134B2 (en) 2018-02-15 2022-06-21 Vesper Medical, Inc. Tapering stent
US11439396B2 (en) 2014-05-02 2022-09-13 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US11628076B2 (en) 2017-09-08 2023-04-18 Vesper Medical, Inc. Hybrid stent
US11628517B2 (en) 2017-06-15 2023-04-18 Howmedica Osteonics Corp. Porous structures produced by additive layer manufacturing
US11712230B2 (en) 2014-05-02 2023-08-01 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US11724075B2 (en) 2017-04-18 2023-08-15 W. L. Gore & Associates, Inc. Deployment constraining sheath that enables staged deployment by device section
US11759341B2 (en) 2020-01-13 2023-09-19 Boston Scientific Scimed, Inc. Anti-migration stent

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807404A (en) * 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US20060173531A1 (en) * 1996-09-19 2006-08-03 Jacob Richter Stent with variable features to optimize support and method of making such stent
US7637942B2 (en) 2002-11-05 2009-12-29 Merit Medical Systems, Inc. Coated stent with geometry determinated functionality and method of making the same
AU2004263171B2 (en) 2003-08-07 2008-12-04 Merit Medical Systems, Inc. Therapeutic medical appliance, delivery and method of use
EP1677706A4 (en) * 2003-09-30 2010-12-29 Merit Medical Systems Inc Removable stent
DE102004012981B4 (en) * 2004-03-16 2009-01-02 Alveolus Inc. stent
US20070213810A1 (en) 2005-03-14 2007-09-13 Richard Newhauser Segmented endoprosthesis
US7837726B2 (en) 2005-03-14 2010-11-23 Abbott Laboratories Visible endoprosthesis
EP1885288B1 (en) * 2005-05-13 2015-03-18 Merit Medical Systems, Inc. Drainage stent and associated method
GB2468861B (en) 2009-03-23 2011-05-18 Cook William Europ Conformable stent structure and method of making same
US20130018215A1 (en) * 2011-01-18 2013-01-17 Merit Medical Systems, Inc. Esophageal stent and methods for use of same
US10285798B2 (en) * 2011-06-03 2019-05-14 Merit Medical Systems, Inc. Esophageal stent
US9283006B2 (en) * 2011-09-22 2016-03-15 Mx Orthopedics, Corp. Osteosynthetic shape memory material intramedullary bone stent and method for treating a bone fracture using the same
US8986368B2 (en) 2011-10-31 2015-03-24 Merit Medical Systems, Inc. Esophageal stent with valve
KR102313261B1 (en) 2012-06-05 2021-10-14 메리트 메디컬 시스템즈, 인크. Esophageal stent
JP6473089B2 (en) 2013-03-05 2019-02-20 メリット・メディカル・システムズ・インコーポレイテッドMerit Medical Systems,Inc. Reinforcing valve
WO2014150130A1 (en) 2013-03-15 2014-09-25 Merit Medical Systems, Inc. Esophageal stent
US11628077B2 (en) * 2016-10-31 2023-04-18 Razmodics Llc Post deployment radial force recovery of biodegradable scaffolds
GB2601856A (en) * 2020-07-01 2022-06-15 Medibrane Ltd Selectively bonded stent assembly and method of manufacturing
CN113069256B (en) * 2021-03-26 2022-12-09 珠海通桥医疗科技有限公司 Intracranial flexible closed loop stent

Citations (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3818511A (en) 1972-11-17 1974-06-25 Medical Prod Corp Medical prosthesis for ducts or conduits
US4343048A (en) 1979-08-06 1982-08-10 Ross Donald N Stent for a cardiac valve
US4441215A (en) 1980-11-17 1984-04-10 Kaster Robert L Vascular graft
US4655771A (en) 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4665906A (en) 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
US4680031A (en) 1982-11-29 1987-07-14 Tascon Medical Technology Corporation Heart valve prosthesis
US4733665A (en) 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4743251A (en) 1983-12-08 1988-05-10 Henry Bocquee Vein prothesis and method for producing same
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4820298A (en) 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
US4820262A (en) 1985-12-12 1989-04-11 Medical Engineering Corporation Ureteral stent
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US5032128A (en) 1988-07-07 1991-07-16 Medtronic, Inc. Heart valve prosthesis
US5061275A (en) 1986-04-21 1991-10-29 Medinvent S.A. Self-expanding prosthesis
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5067957A (en) 1983-10-14 1991-11-26 Raychem Corporation Method of inserting medical devices incorporating SIM alloy elements
US5073694A (en) 1991-02-21 1991-12-17 Synthes (U.S.A.) Method and apparatus for laser cutting a hollow metal workpiece
US5102417A (en) 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5104404A (en) 1989-10-02 1992-04-14 Medtronic, Inc. Articulated stent
US5190546A (en) 1983-10-14 1993-03-02 Raychem Corporation Medical devices incorporating SIM alloy elements
US5195984A (en) 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US5229431A (en) 1990-06-15 1993-07-20 Corvita Corporation Crack-resistant polycarbonate urethane polymer prostheses and the like
US5292331A (en) 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5345057A (en) 1993-03-25 1994-09-06 Lasag Ag Method of cutting an aperture in a device by means of a laser beam
US5354309A (en) 1991-10-11 1994-10-11 Angiomed Ag Apparatus for widening a stenosis in a body cavity
US5356423A (en) 1991-01-04 1994-10-18 American Medical Systems, Inc. Resectable self-expanding stent
US5383925A (en) 1992-09-14 1995-01-24 Meadox Medicals, Inc. Three-dimensional braided soft tissue prosthesis
US5383892A (en) 1991-11-08 1995-01-24 Meadox France Stent for transluminal implantation
US5421955A (en) 1991-10-28 1995-06-06 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5433723A (en) 1991-10-11 1995-07-18 Angiomed Ag Apparatus for widening a stenosis
US5443498A (en) 1991-10-01 1995-08-22 Cook Incorporated Vascular stent and method of making and implanting a vacsular stent
US5449373A (en) 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
US5480431A (en) 1991-07-11 1996-01-02 Willy Rusch Ag Tracheal stent
US5520697A (en) 1992-06-20 1996-05-28 Angiomed Ag Apparatus for correcting the position of a stent
US5534287A (en) 1993-04-23 1996-07-09 Schneider (Europe) A.G. Methods for applying an elastic coating layer on stents
US5562725A (en) 1992-09-14 1996-10-08 Meadox Medicals Inc. Radially self-expanding implantable intraluminal device
US5575818A (en) 1995-02-14 1996-11-19 Corvita Corporation Endovascular stent with locking ring
US5591157A (en) 1994-09-07 1997-01-07 Hennings; David R. Method and apparatus for tympanic membrane shrinkage
US5591197A (en) 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
US5593442A (en) 1995-06-05 1997-01-14 Localmed, Inc. Radially expansible and articulated vessel scaffold
US5601593A (en) 1995-03-06 1997-02-11 Willy Rusch Ag Stent for placement in a body tube
US5609629A (en) 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US5618301A (en) 1993-10-07 1997-04-08 Angiomed Ag Reducing stent, device with reducing stent and use of a reducing stent
US5628788A (en) 1995-11-07 1997-05-13 Corvita Corporation Self-expanding endoluminal stent-graft
US5643312A (en) 1994-02-25 1997-07-01 Fischell Robert Stent having a multiplicity of closed circular structures
US5645559A (en) 1992-05-08 1997-07-08 Schneider (Usa) Inc Multiple layer stent
US5662713A (en) 1991-10-09 1997-09-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5667486A (en) 1993-04-27 1997-09-16 Ams Medinvent, S.A. Prostatic stent
US5674241A (en) 1995-02-22 1997-10-07 Menlo Care, Inc. Covered expanding mesh stent
US5697971A (en) 1996-06-11 1997-12-16 Fischell; Robert E. Multi-cell stent with cells having differing characteristics
US5707386A (en) 1993-02-04 1998-01-13 Angiomed Gmbh & Company Medizintechnik Kg Stent and method of making a stent
US5713949A (en) 1996-08-06 1998-02-03 Jayaraman; Swaminathan Microporous covered stents and method of coating
US5716393A (en) 1994-05-26 1998-02-10 Angiomed Gmbh & Co. Medizintechnik Kg Stent with an end of greater diameter than its main body
US5725572A (en) 1994-04-25 1998-03-10 Advanced Cardiovascular Systems, Inc. Radiopaque stent
US5733303A (en) 1994-03-17 1998-03-31 Medinol Ltd. Flexible expandable stent
US5741333A (en) 1995-04-12 1998-04-21 Corvita Corporation Self-expanding stent for a medical device to be introduced into a cavity of a body
US5755776A (en) 1996-10-04 1998-05-26 Al-Saadon; Khalid Permanent expandable intraluminal tubular stent
US5755781A (en) * 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US5759192A (en) 1994-11-28 1998-06-02 Advanced Cardiovascular Systems, Inc. Method and apparatus for direct laser cutting of metal stents
US5776161A (en) 1995-10-16 1998-07-07 Instent, Inc. Medical stents, apparatus and method for making same
US5807404A (en) 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US5814063A (en) 1994-12-23 1998-09-29 Willy Rusch Ag Stent for placement in a body tube
US5824042A (en) 1996-04-05 1998-10-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US5827321A (en) 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US5833707A (en) 1995-07-05 1998-11-10 Advanced Cardiovascular Systems, Inc. Removable stent and method of deployment
US5837313A (en) 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
US5836966A (en) 1997-05-22 1998-11-17 Scimed Life Systems, Inc. Variable expansion force stent
US5843120A (en) 1994-03-17 1998-12-01 Medinol Ltd. Flexible-expandable stent
US5853419A (en) 1997-03-17 1998-12-29 Surface Genesis, Inc. Stent
US5873904A (en) 1995-06-07 1999-02-23 Cook Incorporated Silver implantable medical device
US5876418A (en) 1994-01-13 1999-03-02 Angiomed Ag Device for providing a duct in a living body
US5876445A (en) 1991-10-09 1999-03-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5876449A (en) 1995-04-01 1999-03-02 Variomed Ag Stent for the transluminal implantation in hollow organs
US5879370A (en) 1994-02-25 1999-03-09 Fischell; Robert E. Stent having a multiplicity of undulating longitudinals
US5902475A (en) 1997-04-08 1999-05-11 Interventional Technologies, Inc. Method for manufacturing a stent
US5911732A (en) 1997-03-10 1999-06-15 Johnson & Johnson Interventional Systems, Co. Articulated expandable intraluminal stent
US5922019A (en) 1995-11-27 1999-07-13 Schneider (Europe) A.G. Conical stent
US5922020A (en) 1996-08-02 1999-07-13 Localmed, Inc. Tubular prosthesis having improved expansion and imaging characteristics
US5931866A (en) 1998-02-24 1999-08-03 Frantzen; John J. Radially expandable stent featuring accordion stops
US5935162A (en) 1998-03-16 1999-08-10 Medtronic, Inc. Wire-tubular hybrid stent
US5938682A (en) 1996-01-26 1999-08-17 Cordis Corporation Axially flexible stent
US5968091A (en) 1996-03-26 1999-10-19 Corvita Corp. Stents and stent grafts having enhanced hoop strength and methods of making the same
US5971950A (en) 1983-01-24 1999-10-26 Icu Medical, Inc. Medical connector
US6017365A (en) 1997-05-20 2000-01-25 Jomed Implantate Gmbh Coronary stent
US6022371A (en) 1996-10-22 2000-02-08 Scimed Life Systems, Inc. Locking stent
US6027527A (en) 1996-12-06 2000-02-22 Piolax Inc. Stent
US6258121B1 (en) * 1999-07-02 2001-07-10 Scimed Life Systems, Inc. Stent coating
US6629994B2 (en) * 2001-06-11 2003-10-07 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6656220B1 (en) * 2002-06-17 2003-12-02 Advanced Cardiovascular Systems, Inc. Intravascular stent

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015549A1 (en) * 1992-12-30 1994-07-21 Schneider (Usa) Inc. Apparatus for deploying body implantable stents
CA2157936C (en) * 1993-03-11 2004-11-02 Gregory Pinchasik Stent
US6685736B1 (en) * 1993-09-30 2004-02-03 Endogad Research Pty Limited Intraluminal graft
US6464722B2 (en) * 1994-03-17 2002-10-15 Medinol, Ltd. Flexible expandable stent
US6719782B1 (en) * 1996-01-04 2004-04-13 Endovascular Technologies, Inc. Flat wire stent
CA2192520A1 (en) * 1996-03-05 1997-09-05 Ian M. Penn Expandable stent and method for delivery of same
US6533805B1 (en) * 1996-04-01 2003-03-18 General Surgical Innovations, Inc. Prosthesis and method for deployment within a body lumen
US6251133B1 (en) * 1996-05-03 2001-06-26 Medinol Ltd. Bifurcated stent with improved side branch aperture and method of making same
WO1997045073A1 (en) * 1996-05-31 1997-12-04 Bard Galway Limited Bifurcated endovascular stents and method and apparatus for their placement
US6174329B1 (en) * 1996-08-22 2001-01-16 Advanced Cardiovascular Systems, Inc. Protective coating for a stent with intermediate radiopaque coating
WO1998012990A1 (en) * 1996-09-26 1998-04-02 Scimed Life Systems, Inc. Support structure/membrane composite medical device
US6325826B1 (en) * 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6692483B2 (en) * 1996-11-04 2004-02-17 Advanced Stent Technologies, Inc. Catheter with attached flexible side sheath
US5906759A (en) * 1996-12-26 1999-05-25 Medinol Ltd. Stent forming apparatus with stent deforming blades
FR2758253B1 (en) * 1997-01-10 1999-04-02 Nycomed Lab Sa IMPLANTABLE DEVICE FOR THE TREATMENT OF A BODY DUCT
US6240616B1 (en) * 1997-04-15 2001-06-05 Advanced Cardiovascular Systems, Inc. Method of manufacturing a medicated porous metal prosthesis
US6451049B2 (en) * 1998-04-29 2002-09-17 Sorin Biomedica Cardio, S.P.A. Stents for angioplasty
IT1292295B1 (en) * 1997-04-29 1999-01-29 Sorin Biomedica Cardio Spa ANGIOPLASTIC STENT
DE19718339A1 (en) * 1997-04-30 1998-11-12 Schering Ag Polymer coated stents, processes for their manufacture and their use for restenosis prophylaxis
DE29708803U1 (en) * 1997-05-17 1997-07-31 Jomed Implantate Gmbh Radially expandable stent for implantation in a body vessel in the area of a vascular branch
BE1011180A6 (en) * 1997-05-27 1999-06-01 Medicorp R & D Benelux Sa Luminal endoprosthesis AUTO EXPANDABLE.
US6723121B1 (en) * 1997-06-18 2004-04-20 Scimed Life Systems, Inc. Polycarbonate-polyurethane dispersions for thrombo-resistant coatings
US6033435A (en) * 1997-11-03 2000-03-07 Divysio Solutions Ulc Bifurcated stent and method for the manufacture and delivery of same
US6267782B1 (en) * 1997-11-20 2001-07-31 St. Jude Medical, Inc. Medical article with adhered antimicrobial metal
US6179867B1 (en) * 1998-01-16 2001-01-30 Advanced Cardiovascular Systems, Inc. Flexible stent and method of use
US6123721A (en) * 1998-02-17 2000-09-26 Jang; G. David Tubular stent consists of chevron-shape expansion struts and ipsilaterally attached M-frame connectors
US6488701B1 (en) * 1998-03-31 2002-12-03 Medtronic Ave, Inc. Stent-graft assembly with thin-walled graft component and method of manufacture
WO1999044543A1 (en) * 1998-03-04 1999-09-10 Scimed Life Systems, Inc. Improved stent cell configurations
US6206916B1 (en) * 1998-04-15 2001-03-27 Joseph G. Furst Coated intraluminal graft
US6436133B1 (en) * 1998-04-15 2002-08-20 Joseph G. Furst Expandable graft
US6042597A (en) * 1998-10-23 2000-03-28 Scimed Life Systems, Inc. Helical stent design
US6673102B1 (en) * 1999-01-22 2004-01-06 Gore Enterprises Holdings, Inc. Covered endoprosthesis and delivery system
US6361557B1 (en) * 1999-02-05 2002-03-26 Medtronic Ave, Inc. Staplebutton radiopaque marker
US6695876B1 (en) * 1999-02-12 2004-02-24 Thomas R. Marotta Endovascular prosthesis
DE29904817U1 (en) * 1999-03-16 1999-05-27 Amg Handelsgesellschaft Fuer A Blood vessel support device
US6673103B1 (en) * 1999-05-20 2004-01-06 Scimed Life Systems, Inc. Mesh and stent for increased flexibility
US6679910B1 (en) * 1999-11-12 2004-01-20 Latin American Devices Llc Intraluminal stent
US6673107B1 (en) * 1999-12-06 2004-01-06 Advanced Cardiovascular Systems, Inc. Bifurcated stent and method of making
US6981987B2 (en) * 1999-12-22 2006-01-03 Ethicon, Inc. Removable stent for body lumens
US6344044B1 (en) * 2000-02-11 2002-02-05 Edwards Lifesciences Corp. Apparatus and methods for delivery of intraluminal prosthesis
CA2345604A1 (en) * 2000-05-02 2001-11-02 Cordis Corporation Bifurcated stent and stent delivery system
WO2001095876A1 (en) * 2000-06-09 2001-12-20 Baylor College Of Medicine The combination of antimicrobial agents and bacterial interference to coat medical devices
US6723373B1 (en) * 2000-06-16 2004-04-20 Cordis Corporation Device and process for coating stents
US6540775B1 (en) * 2000-06-30 2003-04-01 Cordis Corporation Ultraflexible open cell stent
US6709451B1 (en) * 2000-07-14 2004-03-23 Norman Noble, Inc. Channeled vascular stent apparatus and method
CA2421804C (en) * 2000-09-25 2009-05-12 Boston Scientific Limited Intravascular stent apparatus
US6695833B1 (en) * 2000-09-27 2004-02-24 Nellix, Inc. Vascular stent-graft apparatus and forming method
AU2002233936A1 (en) * 2000-11-07 2002-05-21 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal stent, self-fupporting endoluminal graft and methods of making same
US6540777B2 (en) * 2001-02-15 2003-04-01 Scimed Life Systems, Inc. Locking stent
US6679911B2 (en) * 2001-03-01 2004-01-20 Cordis Corporation Flexible stent
US6673104B2 (en) * 2001-03-15 2004-01-06 Scimed Life Systems, Inc. Magnetic stent
US6673105B1 (en) * 2001-04-02 2004-01-06 Advanced Cardiovascular Systems, Inc. Metal prosthesis coated with expandable ePTFE
US6685745B2 (en) * 2001-05-15 2004-02-03 Scimed Life Systems, Inc. Delivering an agent to a patient's body
US6749628B1 (en) * 2001-05-17 2004-06-15 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6673154B1 (en) * 2001-06-28 2004-01-06 Advanced Cardiovascular Systems, Inc. Stent mounting device to coat a stent
US7547321B2 (en) * 2001-07-26 2009-06-16 Alveolus Inc. Removable stent and method of using the same
US6908480B2 (en) * 2001-08-29 2005-06-21 Swaminathan Jayaraman Structurally variable stents
US20030077310A1 (en) * 2001-10-22 2003-04-24 Chandrashekhar Pathak Stent coatings containing HMG-CoA reductase inhibitors

Patent Citations (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3818511A (en) 1972-11-17 1974-06-25 Medical Prod Corp Medical prosthesis for ducts or conduits
US4343048A (en) 1979-08-06 1982-08-10 Ross Donald N Stent for a cardiac valve
US4441215A (en) 1980-11-17 1984-04-10 Kaster Robert L Vascular graft
US4655771A (en) 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4655771B1 (en) 1982-04-30 1996-09-10 Medinvent Ams Sa Prosthesis comprising an expansible or contractile tubular body
US4680031A (en) 1982-11-29 1987-07-14 Tascon Medical Technology Corporation Heart valve prosthesis
US5971950A (en) 1983-01-24 1999-10-26 Icu Medical, Inc. Medical connector
US5067957A (en) 1983-10-14 1991-11-26 Raychem Corporation Method of inserting medical devices incorporating SIM alloy elements
US4665906A (en) 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
US5597378A (en) 1983-10-14 1997-01-28 Raychem Corporation Medical devices incorporating SIM alloy elements
US5190546A (en) 1983-10-14 1993-03-02 Raychem Corporation Medical devices incorporating SIM alloy elements
US4743251A (en) 1983-12-08 1988-05-10 Henry Bocquee Vein prothesis and method for producing same
US4739762A (en) 1985-11-07 1988-04-26 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4733665A (en) 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5102417A (en) 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4739762B1 (en) 1985-11-07 1998-10-27 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4733665B1 (en) 1985-11-07 1994-01-11 Expandable Grafts Partnership Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft
US4820262A (en) 1985-12-12 1989-04-11 Medical Engineering Corporation Ureteral stent
US5061275A (en) 1986-04-21 1991-10-29 Medinvent S.A. Self-expanding prosthesis
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US4820298A (en) 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
US5032128A (en) 1988-07-07 1991-07-16 Medtronic, Inc. Heart valve prosthesis
US5195984A (en) 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US5292331A (en) 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5104404A (en) 1989-10-02 1992-04-14 Medtronic, Inc. Articulated stent
US5229431A (en) 1990-06-15 1993-07-20 Corvita Corporation Crack-resistant polycarbonate urethane polymer prostheses and the like
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5356423A (en) 1991-01-04 1994-10-18 American Medical Systems, Inc. Resectable self-expanding stent
US5073694A (en) 1991-02-21 1991-12-17 Synthes (U.S.A.) Method and apparatus for laser cutting a hollow metal workpiece
US5480431A (en) 1991-07-11 1996-01-02 Willy Rusch Ag Tracheal stent
US5443498A (en) 1991-10-01 1995-08-22 Cook Incorporated Vascular stent and method of making and implanting a vacsular stent
US5876445A (en) 1991-10-09 1999-03-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5662713A (en) 1991-10-09 1997-09-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5354309A (en) 1991-10-11 1994-10-11 Angiomed Ag Apparatus for widening a stenosis in a body cavity
US5540713A (en) 1991-10-11 1996-07-30 Angiomed Ag Apparatus for widening a stenosis in a body cavity
US5433723A (en) 1991-10-11 1995-07-18 Angiomed Ag Apparatus for widening a stenosis
US5766238A (en) 1991-10-28 1998-06-16 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5514154A (en) 1991-10-28 1996-05-07 Advanced Cardiovascular Systems, Inc. Expandable stents
US5421955A (en) 1991-10-28 1995-06-06 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5421955B1 (en) 1991-10-28 1998-01-20 Advanced Cardiovascular System Expandable stents and method for making same
US5383892A (en) 1991-11-08 1995-01-24 Meadox France Stent for transluminal implantation
US5645559A (en) 1992-05-08 1997-07-08 Schneider (Usa) Inc Multiple layer stent
US5876448A (en) 1992-05-08 1999-03-02 Schneider (Usa) Inc. Esophageal stent
US5520697A (en) 1992-06-20 1996-05-28 Angiomed Ag Apparatus for correcting the position of a stent
US5562725A (en) 1992-09-14 1996-10-08 Meadox Medicals Inc. Radially self-expanding implantable intraluminal device
US5383925A (en) 1992-09-14 1995-01-24 Meadox Medicals, Inc. Three-dimensional braided soft tissue prosthesis
US5860999A (en) 1993-02-04 1999-01-19 Angiomed Gmbh & Co.Medizintechnik Kg Stent and method of using same
US5707386A (en) 1993-02-04 1998-01-13 Angiomed Gmbh & Company Medizintechnik Kg Stent and method of making a stent
US5345057A (en) 1993-03-25 1994-09-06 Lasag Ag Method of cutting an aperture in a device by means of a laser beam
US5534287A (en) 1993-04-23 1996-07-09 Schneider (Europe) A.G. Methods for applying an elastic coating layer on stents
US5667486A (en) 1993-04-27 1997-09-16 Ams Medinvent, S.A. Prostatic stent
US5618301A (en) 1993-10-07 1997-04-08 Angiomed Ag Reducing stent, device with reducing stent and use of a reducing stent
US5876418A (en) 1994-01-13 1999-03-02 Angiomed Ag Device for providing a duct in a living body
US5879370A (en) 1994-02-25 1999-03-09 Fischell; Robert E. Stent having a multiplicity of undulating longitudinals
US5643312A (en) 1994-02-25 1997-07-01 Fischell Robert Stent having a multiplicity of closed circular structures
US5972018A (en) 1994-03-17 1999-10-26 Medinol Ltd. Flexible expandable stent
US5980552A (en) 1994-03-17 1999-11-09 Medinol Ltd. Articulated stent
US5449373A (en) 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
US5733303A (en) 1994-03-17 1998-03-31 Medinol Ltd. Flexible expandable stent
US5843120A (en) 1994-03-17 1998-12-01 Medinol Ltd. Flexible-expandable stent
US5725572A (en) 1994-04-25 1998-03-10 Advanced Cardiovascular Systems, Inc. Radiopaque stent
US5716393A (en) 1994-05-26 1998-02-10 Angiomed Gmbh & Co. Medizintechnik Kg Stent with an end of greater diameter than its main body
US5591157A (en) 1994-09-07 1997-01-07 Hennings; David R. Method and apparatus for tympanic membrane shrinkage
US5780807A (en) 1994-11-28 1998-07-14 Advanced Cardiovascular Systems, Inc. Method and apparatus for direct laser cutting of metal stents
US5759192A (en) 1994-11-28 1998-06-02 Advanced Cardiovascular Systems, Inc. Method and apparatus for direct laser cutting of metal stents
US5814063A (en) 1994-12-23 1998-09-29 Willy Rusch Ag Stent for placement in a body tube
US5575818A (en) 1995-02-14 1996-11-19 Corvita Corporation Endovascular stent with locking ring
US5968070A (en) 1995-02-22 1999-10-19 Cordis Corporation Covered expanding mesh stent
US5674241A (en) 1995-02-22 1997-10-07 Menlo Care, Inc. Covered expanding mesh stent
US5601593A (en) 1995-03-06 1997-02-11 Willy Rusch Ag Stent for placement in a body tube
US5681346A (en) 1995-03-14 1997-10-28 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
US5591197A (en) 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
US5876449A (en) 1995-04-01 1999-03-02 Variomed Ag Stent for the transluminal implantation in hollow organs
US5741333A (en) 1995-04-12 1998-04-21 Corvita Corporation Self-expanding stent for a medical device to be introduced into a cavity of a body
US5837313A (en) 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
US5593442A (en) 1995-06-05 1997-01-14 Localmed, Inc. Radially expansible and articulated vessel scaffold
US5609629A (en) 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US5873904A (en) 1995-06-07 1999-02-23 Cook Incorporated Silver implantable medical device
US5833707A (en) 1995-07-05 1998-11-10 Advanced Cardiovascular Systems, Inc. Removable stent and method of deployment
US5776161A (en) 1995-10-16 1998-07-07 Instent, Inc. Medical stents, apparatus and method for making same
US5628788A (en) 1995-11-07 1997-05-13 Corvita Corporation Self-expanding endoluminal stent-graft
US5922019A (en) 1995-11-27 1999-07-13 Schneider (Europe) A.G. Conical stent
US5938682A (en) 1996-01-26 1999-08-17 Cordis Corporation Axially flexible stent
US5968091A (en) 1996-03-26 1999-10-19 Corvita Corp. Stents and stent grafts having enhanced hoop strength and methods of making the same
US5824042A (en) 1996-04-05 1998-10-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US5697971A (en) 1996-06-11 1997-12-16 Fischell; Robert E. Multi-cell stent with cells having differing characteristics
US5922020A (en) 1996-08-02 1999-07-13 Localmed, Inc. Tubular prosthesis having improved expansion and imaging characteristics
US5755781A (en) * 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US5922393A (en) 1996-08-06 1999-07-13 Jayaraman; Swaminathan Microporous covered stents and method of coating
US5713949A (en) 1996-08-06 1998-02-03 Jayaraman; Swaminathan Microporous covered stents and method of coating
US5807404A (en) 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US5755776A (en) 1996-10-04 1998-05-26 Al-Saadon; Khalid Permanent expandable intraluminal tubular stent
US6022371A (en) 1996-10-22 2000-02-08 Scimed Life Systems, Inc. Locking stent
US6027527A (en) 1996-12-06 2000-02-22 Piolax Inc. Stent
US5827321A (en) 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US5911732A (en) 1997-03-10 1999-06-15 Johnson & Johnson Interventional Systems, Co. Articulated expandable intraluminal stent
US5853419A (en) 1997-03-17 1998-12-29 Surface Genesis, Inc. Stent
US5902475A (en) 1997-04-08 1999-05-11 Interventional Technologies, Inc. Method for manufacturing a stent
US6017365A (en) 1997-05-20 2000-01-25 Jomed Implantate Gmbh Coronary stent
US5836966A (en) 1997-05-22 1998-11-17 Scimed Life Systems, Inc. Variable expansion force stent
US5931866A (en) 1998-02-24 1999-08-03 Frantzen; John J. Radially expandable stent featuring accordion stops
US5935162A (en) 1998-03-16 1999-08-10 Medtronic, Inc. Wire-tubular hybrid stent
US6258121B1 (en) * 1999-07-02 2001-07-10 Scimed Life Systems, Inc. Stent coating
US6629994B2 (en) * 2001-06-11 2003-10-07 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6656220B1 (en) * 2002-06-17 2003-12-02 Advanced Cardiovascular Systems, Inc. Intravascular stent

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
D.H. Kim et al., Evaluation of the Biodurability of Polyurethane Covered Stent Using a Flow Phantom, Korean J. Radiology, Jun. 2001: 2:75-79.
PCT Notification of Transmittal of the International Search Report, PCT International Search Report mailed Jan. 18, 2006 for PCT/US04/31304 (Filed Sep. 24, 2004).
PCT Notification of Transmittal of the International Search Report, PCT International Search Report mailed Mar. 9, 2005 for PCT/US04/31898 (Filed Sep. 29, 2004).
Supplementary European Search Report for EP 03 77 6570, completed Apr. 30, 2007, mailed on May 14, 2007.
U.S. Appl. No. 08/246,320, filed May 19, 1994, Burnmeister et al.

Cited By (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160302947A1 (en) * 2006-10-06 2016-10-20 Abbott Cardiovascular Systems Inc. Intravascular stent
US9801743B2 (en) * 2006-10-06 2017-10-31 Abbott Cardiovascular Systems Inc. Intravascular stent
US20090281615A1 (en) * 2008-05-08 2009-11-12 Boston Scientific Scimed, Inc. Stent with tabs and holes for drug delivery
US8114151B2 (en) * 2008-05-08 2012-02-14 Boston Scientific Scimed, Inc. Stent with tabs and holes for drug delivery
US10058444B2 (en) 2009-08-24 2018-08-28 Qualimed Innovative Medizinprodukte Gmbh Implantation system with handle and catheter and method of use thereof
US9999531B2 (en) 2009-08-24 2018-06-19 Qualimed Innovative Medizinprodukte Gmbh Variable scale stent deployment device
US20110046710A1 (en) * 2009-08-24 2011-02-24 Qualimed Gmbh Implantation device with handle and method of use thereof
US10137022B2 (en) 2009-08-24 2018-11-27 Qualimed Innovative Medizinprodukte Gmbh Implantation device with handle and method of use thereof
US9393139B2 (en) 2009-08-24 2016-07-19 Qualimed Innovative Medizinprodukte Gmbh Implantation system with handle and catheter and method of use thereof
US9414943B2 (en) 2009-08-24 2016-08-16 Qualimed Innovative Medizinprodukte Gmbh Implantation system with handle and catheter and method of use thereof
US10779977B2 (en) 2009-08-24 2020-09-22 Qualimed Innovative Medizinprodukte Gmbh Variable scale stent deployment device
US10485685B2 (en) 2009-08-24 2019-11-26 Qualimed Innovative Medizinprodukte Gmbh Implantation system with handle and catheter and method of use thereof
US11051958B2 (en) * 2012-03-09 2021-07-06 Q3 Medical Devices Limited Biodegradable supporting device
US20140356407A1 (en) * 2012-03-09 2014-12-04 Q3 Medical Devices Limited Biodegradable supporting device
WO2013172938A1 (en) * 2012-05-14 2013-11-21 C.R. Bard, Inc. Uniformly expandable stent
US9066825B2 (en) 2012-05-14 2015-06-30 C.R. Bard, Inc. Uniformly expandable stent
US10588765B2 (en) 2012-05-14 2020-03-17 C. R. Bard, Inc. Uniformly expandable stent
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
US10842656B2 (en) 2013-03-15 2020-11-24 Atrium Medical Corporation Stent device having reduced foreshortening and recoil and method of making same
US10271975B2 (en) 2013-03-15 2019-04-30 Atrium Medical Corporation Stent device having reduced foreshortening and recoil and method of making same
US9907684B2 (en) 2013-05-08 2018-03-06 Aneuclose Llc Method of radially-asymmetric stent expansion
US9700401B2 (en) 2013-09-12 2017-07-11 Boston Scientific Scimed, Inc. Stent with anti-migration connectors
US10117763B2 (en) 2014-03-18 2018-11-06 Boston Scientific Scimed, Inc. Reduced granulation and inflammation stent design
US11596409B2 (en) 2014-05-02 2023-03-07 W.L. Gore & Associates, Inc. Anastomosis devices
US11712230B2 (en) 2014-05-02 2023-08-01 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US11439396B2 (en) 2014-05-02 2022-09-13 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US11344307B2 (en) * 2014-05-02 2022-05-31 W. L. Gore & Associates, Inc. Anastomosis devices
US11590008B2 (en) 2014-10-02 2023-02-28 Boston Scientific Scimed, Inc. Controlled ingrowth feature for antimigration
US10219921B2 (en) 2014-10-02 2019-03-05 Boston Scientific Scimed, Inc. Controlled ingrowth feature for antimigration
US9381103B2 (en) * 2014-10-06 2016-07-05 Abbott Cardiovascular Systems Inc. Stent with elongating struts
US10130498B2 (en) 2014-10-22 2018-11-20 Boston Scientific Scimed, Inc. Stent with flexible hinge
US10898354B2 (en) 2014-11-06 2021-01-26 Boston Scientific Scimed, Inc. Tracheal stent
US10596660B2 (en) 2015-12-15 2020-03-24 Howmedica Osteonics Corp. Porous structures produced by additive layer manufacturing
US11484422B2 (en) 2016-03-31 2022-11-01 Vesper Medical, Inc. Intravascular implants
US10758381B2 (en) 2016-03-31 2020-09-01 Vesper Medical, Inc. Intravascular implants
US10702405B2 (en) 2016-03-31 2020-07-07 Vesper Medical, Inc. Intravascular implants
US11628075B2 (en) 2016-03-31 2023-04-18 Vesper Medical, Inc. Intravascular implants
US11724075B2 (en) 2017-04-18 2023-08-15 W. L. Gore & Associates, Inc. Deployment constraining sheath that enables staged deployment by device section
US11628517B2 (en) 2017-06-15 2023-04-18 Howmedica Osteonics Corp. Porous structures produced by additive layer manufacturing
US10849769B2 (en) 2017-08-23 2020-12-01 Vesper Medical, Inc. Non-foreshortening stent
US10588764B2 (en) 2017-09-08 2020-03-17 Vesper Medical, Inc. Hybrid stent
US11376142B2 (en) 2017-09-08 2022-07-05 Vesper Medical, Inc. Hybrid stent
US10512556B2 (en) 2017-09-08 2019-12-24 Vesper Medical, Inc. Hybrid stent
US11628076B2 (en) 2017-09-08 2023-04-18 Vesper Medical, Inc. Hybrid stent
US10271977B2 (en) 2017-09-08 2019-04-30 Vesper Medical, Inc. Hybrid stent
US10888362B2 (en) 2017-11-03 2021-01-12 Howmedica Osteonics Corp. Flexible construct for femoral reconstruction
US11890041B2 (en) 2017-11-03 2024-02-06 Howmedica Osteonics Corp. Flexible construct for femoral reconstruction
US11364134B2 (en) 2018-02-15 2022-06-21 Vesper Medical, Inc. Tapering stent
US10500078B2 (en) 2018-03-09 2019-12-10 Vesper Medical, Inc. Implantable stent
US11344439B2 (en) 2018-03-09 2022-05-31 Vesper Medical, Inc. Implantable stent
US11357650B2 (en) 2019-02-28 2022-06-14 Vesper Medical, Inc. Hybrid stent
US11759341B2 (en) 2020-01-13 2023-09-19 Boston Scientific Scimed, Inc. Anti-migration stent

Also Published As

Publication number Publication date
DE60328507D1 (en) 2009-09-03
CA2505121A1 (en) 2004-05-27
US20040088040A1 (en) 2004-05-06
WO2004043221A2 (en) 2004-05-27
EP1558178A2 (en) 2005-08-03
JP2006505347A (en) 2006-02-16
WO2004043221A3 (en) 2005-01-27
EP1558178A4 (en) 2007-06-13
AU2003284180B2 (en) 2009-01-08
JP4431046B2 (en) 2010-03-10
EP1558178B1 (en) 2009-07-22
AU2003284180A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
US7527644B2 (en) Stent with geometry determinated functionality and method of making the same
US7875068B2 (en) Removable biliary stent
EP2594229B1 (en) Covered stent with geometry determinated functionality and method of making the same
JP4278874B2 (en) Stent having struts with different geometric shapes
US7625398B2 (en) Endoprosthesis having foot extensions
US8016874B2 (en) Flexible stent with elevated scaffolding properties
EP1346706A1 (en) Stent with enhanced crossability
US7959671B2 (en) Differential covering and coating methods
EP1689328A1 (en) Differential covering and coating methods

Legal Events

Date Code Title Description
AS Assignment

Owner name: ALVEOLUS INC, NORTH CAROLINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MANGIARDI, ERIC K.;REYNOLDS, JASON M.;REEL/FRAME:014071/0175

Effective date: 20031023

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: MERIT MEDICAL SYSTEMS, INC., UTAH

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ALVEOLUS, INC.;REEL/FRAME:022666/0821

Effective date: 20090310

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINIS

Free format text: PATENT SECURITY AGREEMENT;ASSIGNOR:MERIT MEDICAL SYSTEMS, INC.;REEL/FRAME:029698/0033

Effective date: 20121219

Owner name: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT, UTAH

Free format text: PATENT SECURITY AGREEMENT;ASSIGNOR:MERIT MEDICAL SYSTEMS, INC.;REEL/FRAME:029698/0033

Effective date: 20121219

FPAY Fee payment

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: 11.5 YR SURCHARGE- LATE PMT W/IN 6 MO, LARGE ENTITY (ORIGINAL EVENT CODE: M1556); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 12